Castle Biosciences Inc.
(CSTL)
undefined
undefined%
At close: undefined
28.87
0.14%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | 219.79M | 137.04M | 94.08M | 62.65M | 51.87M | 22.79M | 13.75M |
| Cost of Revenue | 44.98M | 32.01M | 15.82M | 9.69M | 7.31M | 5.30M | 4.92M |
| Gross Profit | 174.81M | 105.03M | 78.26M | 52.96M | 44.55M | 17.49M | 8.83M |
| Operating Income | -67.98M | -91.14M | -40.08M | -6.54M | 4.71M | -3.84M | -10.90M |
| Interest Income | 10.62M | 3.97M | 68.00K | 373.00K | 312.00K | 23.51K | 26.18K |
| Pretax Income | -57.37M | -68.90M | -40.01M | -10.20M | 5.35M | -6.36M | -12.36M |
| Net Income | -57.47M | -67.14M | -31.29M | -10.28M | 5.28M | -6.37M | -12.37M |
| Selling & General & Admin | 180.15M | 143.00M | 86.74M | 48.13M | 29.84M | 16.47M | 15.26M |
| Research & Development | 53.62M | 44.90M | 29.65M | 13.26M | 7.38M | 4.85M | 4.47M |
| Other Expenses | 9.01M | 8.27M | 1.96M | -1.88M | -2.93M | -272.42K | 163.29K |
| Operating Expenses | 242.78M | 196.17M | 118.34M | 59.51M | 37.23M | 21.32M | 19.73M |
| Interest Expense | 11.00K | 17.00K | 1K | 2.63M | 4.57M | 2.27M | 1.65M |
| Selling & Marketing Expenses | 113.66M | 86.61M | - | - | - | - | - |
| Cost & Expenses | 287.76M | 228.18M | 134.16M | 69.19M | 44.54M | 26.62M | 24.65M |
| Income Tax | 101.00K | -1.77M | -8.72M | 84.00K | 72.00K | 8.61K | 9.73K |
| Shares Outstanding (Basic) | 26.80M | 26.05M | 25.14M | 18.93M | 8.58M | 10.65M | 9.78M |
| Shares Outstanding (Diluted) | 26.80M | 26.05M | 25.14M | 18.93M | 8.66M | 10.65M | 9.78M |
| EPS (Basic) | -2.14 | -2.58 | -1.24 | -0.54 | 0.35 | -0.6 | -1.26 |
| EPS (Diluted) | -2.14 | -2.58 | -1.24 | -0.54 | -0.21 | -0.6 | -1.26 |
| EBITDA | -45.02M | -58.34M | -36.60M | -7.09M | 7.69M | -3.76M | -10.40M |
| Depreciation & Amortization | 12.33M | 10.54M | 3.41M | 472.00K | 358.00K | 323.02K | 310.82K |